Ovarian Cancer

>

Latest News

Novel CDK2 Inhibitor INCB123667 Shows Promise in Ovarian Cancer
Novel CDK2 Inhibitor INCB123667 Shows Promise in Ovarian Cancer

July 11th 2025

The CDK2 inhibitor INCB123667 showed positive efficacy and safety signals in platinum-resistant/refractory ovarian cancer.

Pembrolizumab Improves PFS in Recurrent Ovarian Cancer
Pembrolizumab Improves PFS in Recurrent Ovarian Cancer

May 15th 2025

Avutometinib Plus Defactinib Gains FDA Approval in KRAS+ Ovarian Cancer
Avutometinib Plus Defactinib Gains FDA Approval in KRAS+ Ovarian Cancer

May 8th 2025

FDA Fast-Tracks INX-315 in Ovarian Cancer
FDA Fast-Tracks INX-315 in Ovarian Cancer

May 1st 2025

Krivak on PARP Inhibitors and Maintenance Therapy in Ovarian Cancer
Krivak on PARP Inhibitors and Maintenance Therapy in Ovarian Cancer

April 14th 2025

Video Series
Video Interviews

More News